Private Trust Co. NA Has $1,361,000 Stake in Baxter International Inc. (BAX)
Private Trust Co. NA decreased its stake in Baxter International Inc. (NYSE:BAX) by 1.5% during the third quarter, according to its most recent disclosure with the SEC. The firm owned 28,601 shares of the company’s stock after selling 435 shares during the period. Private Trust Co. NA’s holdings in Baxter International were worth $1,361,000 as of its most recent filing with the SEC.
Other large investors have also modified their holdings of the company. Bank of New York Mellon Corp boosted its stake in shares of Baxter International by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 5,530,764 shares of the company’s stock valued at $250,102,000 after buying an additional 343,725 shares in the last quarter. TIAA CREF Investment Management LLC raised its position in Baxter International by 1.0% in the second quarter. TIAA CREF Investment Management LLC now owns 3,966,516 shares of the company’s stock valued at $179,366,000 after buying an additional 39,887 shares during the last quarter. BNP Paribas Arbitrage SA raised its position in Baxter International by 753.5% in the second quarter. BNP Paribas Arbitrage SA now owns 2,281,030 shares of the company’s stock valued at $103,148,000 after buying an additional 2,013,786 shares during the last quarter. California Public Employees Retirement System raised its position in Baxter International by 39.5% in the second quarter. California Public Employees Retirement System now owns 2,059,667 shares of the company’s stock valued at $93,138,000 after buying an additional 583,144 shares during the last quarter. Finally, UBS Asset Management Americas Inc. raised its position in Baxter International by 18.3% in the second quarter. UBS Asset Management Americas Inc. now owns 2,042,142 shares of the company’s stock valued at $92,346,000 after buying an additional 316,399 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Baxter International Inc. (NYSE:BAX) traded down 0.24% during mid-day trading on Monday, hitting $46.61. 2,468,027 shares of the stock were exchanged. The stock has a 50 day moving average price of $47.22 and a 200 day moving average price of $46.46. The company has a market capitalization of $25.35 billion, a PE ratio of 5.22 and a beta of 0.88. Baxter International Inc. has a 1-year low of $34.06 and a 1-year high of $50.16.
Baxter International (NYSE:BAX) last released its earnings results on Tuesday, October 25th. The company reported $0.56 earnings per share for the quarter, beating analysts’ consensus estimates of $0.45 by $0.11. The business earned $2.56 billion during the quarter, compared to the consensus estimate of $2.67 billion. Baxter International had a net margin of 48.68% and a return on equity of 11.43%. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.41 EPS. On average, equities analysts anticipate that Baxter International Inc. will post $1.91 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, January 3rd. Shareholders of record on Friday, December 2nd will be given a dividend of $0.13 per share. This represents a $0.52 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Wednesday, November 30th. Baxter International’s dividend payout ratio is presently 5.83%.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and republished in violation of US and international trademark and copyright laws. The correct version of this piece can be read at https://www.thecerbatgem.com/2016/11/29/private-trust-co-na-has-1361000-stake-in-baxter-international-inc-bax.html.
BAX has been the topic of several recent analyst reports. Zacks Investment Research lowered shares of Baxter International from a “buy” rating to a “hold” rating in a research note on Monday, October 17th. Barclays PLC initiated coverage on shares of Baxter International in a research note on Thursday, September 15th. They set an “overweight” rating and a $52.00 price objective on the stock. Evercore ISI reissued a “buy” rating and set a $56.00 price objective (up previously from $52.00) on shares of Baxter International in a research note on Wednesday, October 26th. Wells Fargo & Co. initiated coverage on shares of Baxter International in a research note on Thursday, October 13th. They set an “outperform” rating on the stock. Finally, Royal Bank Of Canada lifted their price objective on shares of Baxter International from $50.00 to $55.00 and gave the stock a “sector perform” rating in a research note on Wednesday, October 26th. One analyst has rated the stock with a sell rating, seven have given a hold rating and six have assigned a buy rating to the stock. The stock has a consensus rating of “Hold” and a consensus price target of $51.30.
Baxter International Company Profile
Baxter International Inc, through its subsidiaries, provides a portfolio of essential renal and hospital products, including home, acute and in-center dialysis; sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics, and pharmacy automation, software and services.
Receive News & Stock Ratings for Baxter International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International Inc. and related stocks with our FREE daily email newsletter.